HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
AZD 3355
Description
AZD 3355 is a reflux inhibitor used for the treatment of Gastroesophageal Reflux Disease. It is developed by AstraZeneca and is currently in phase I/II trials.
No brand information found.